The FDA released its assessment of Johnson & Johnson’s booster shot
A two-day meeting of Food and Drug Administration (FDA) advisers starts on Thursday and a committee will discuss recommending booster…
A two-day meeting of Food and Drug Administration (FDA) advisers starts on Thursday and a committee will discuss recommending booster shots for the Moderna and Johnson & Johnson COVID-19 vaccines. Moderna seeks authorization of a third dose of its vaccine that is a half-sized dose for certain high-risk groups who have been fully vaccinated for at least six months, according to NPR.
An FDA panel is set to begin two days of meetings that are expected to strongly influence whether at least some recipients of the Moderna and Johnson & Johnson Covid vaccines should get booster shots.
People who received a Johnson & Johnson coronavirus vaccine may be better off with a booster from Moderna or Pfizer, according to early data from a U.S. clinical trial. FDA advisers will discuss the findings on Friday.
What people are saying?
Cory Simenson Of course the NYT would push the mRNA vaccines. That’s what they’ve been doing this whole time. “Yes, let’s test out this lipid that’s never been used in a vaccine.” My hesitation was because of constant “news” reports about the vaccines. Constant conflicting info.
Matt Kapinus I thought I could just nebulously cheer for vaccines and make the claim that since you got jabbed for school, military, etc, that you should just take this one. You mean they’re not all created equally?